One critical area where greater diversity and inclusion are needed is stroke research. Stroke is a leading cause of death and disability worldwide, yet its impact varies significantly among different populations. Certain groups experience higher stroke rates, greater disability, and worse outcomes compared to others due to unique risk factors such as higher rates of conditions like hypertension and diabetes. Despite this, these populations remain underrepresented in stroke studies, often comprising less than 10% of clinical trial participants. This lack of inclusion limits the ability to develop targeted prevention strategies and effective treatments. Stroke recovery can also differ based on cultural, linguistic, and socioeconomic factors, which are rarely addressed in research. Additionally, access to advanced treatments like clot retrieval therapy is often inequitable, further widening health disparities. Including more diverse populations in stroke, research is essential for creating interventions that account for genetic variations, environmental influences, and barriers to care. It also ensures that patients from all backgrounds benefit from advancements in treatment. By improving inclusion in research, it is possible to achieve better outcomes across communities, reduce disparities, and provide more personalized and effective care for one of the most urgent neurological challenges of our time.
In particular, dosing protocols suffer from male-centered research. While a medication may work on both sexes, idiosyncrasies in dosing can interfere with effectiveness. And it's not always altered in the way you might expect. While women tend to be smaller, it's a mistake to assume that means they need less of a drug. They're actually often likely to be paradoxically effected, meaning they need more, not less, to reach peak efficacy. Hormones may play a role in this. To understand why and when sex-based dosing is appropriate, we first need to focus on diversifying research. The field has too long prioritized men. Many studies eschew women entirely, ostensibly due to a fear of potential pregnancy, but this is an avoidable issue in larger samples. We're doing half the population an enormous disservice by not including women in dosing studies.
One area where greater diversity and inclusion are urgently needed is in clinical trials for new medications and treatments. As an experienced dentist, I've seen firsthand how patients from different backgrounds can respond differently to treatments based on genetics, lifestyle, or socio-economic factors. Unfortunately, clinical trials often lack representation from minority groups, leading to treatments that may not be as effective or safe for all populations. Diversity in medical research ensures that findings apply to everyone, not just a subset of the population. For example, oral medications for gum disease might work differently in individuals with varying diets or genetic predispositions. Without inclusive research, dentists like me risk recommending treatments that aren't universally effective, leaving certain groups underserved. By fostering inclusivity, medical research can create solutions that work for everyone. This involves outreach to underrepresented communities, removing barriers to participation, and ensuring ethical practices. A diverse pool of research subjects benefits both patients and practitioners by paving the way for personalized and equitable care.
One area where I see a critical need for greater diversity and inclusion is in the research and development of treatment protocols for musculoskeletal and postural health issues. Historically, much of the research has been conducted on populations that do not adequately represent the diversity of body types, cultural backgrounds, and lifestyles that exist in the broader community. This lack of inclusivity can result in treatment approaches that fail to address the specific needs of underrepresented groups, such as women, people of different ethnic backgrounds, or individuals with unique physical demands due to their profession or lifestyle. Greater diversity in research would ensure that treatment protocols are not only effective but also equitable, addressing the full spectrum of needs across our population. A prime example of this in my career was during my time working with elite athletes, particularly the Australian Judo team, where I treated individuals from a variety of cultural and physical backgrounds. My training and experience allowed me to tailor rehabilitation programs to the specific biomechanical needs of each athlete, taking into account factors like body structure, cultural movement patterns, and even diet. In one case, I worked with a high-performing judo athlete from a Pacific Island background who had recurring lower back pain. By integrating culturally relevant approaches such as movement patterns from traditional Pacific dance into their rehabilitation, we achieved faster recovery and improved performance. This experience reinforced the importance of recognizing and incorporating diversity into both research and practical application. It's not just about healing, it is about providing personalized care that empowers individuals to thrive.